← Today’s ReceiptsOfficial public filing linked
Public-record receiptR-FLOfficial filing linked
Laurel Lee disclosed BUY $PFE
Here’s the public record: who traded, what they disclosed, when it happened, how late it appeared, and what context is attached.
Trade range
$15K – $50K
Filed
2024-10-23
Trade date
2024-10-21
Disclosure lag
2 days after trade
Why this receipt matters
A quick read before you share it.
These are factual context points from the receipt and linked public-record data. They explain why the disclosure may be worth opening, not whether anyone acted improperly.
1The receipt links to an official public filing, so readers can verify the underlying disclosure before sharing.
2The filing appeared 2 days after trade, which helps separate trade timing from filing timing.
3The disclosed range is $15K – $50K, which is the public reporting band rather than an exact profit or loss figure.
45 nearby same-ticker disclosures appeared in the surrounding 30-day window.
5Committee context is available for Laurel Lee, but PoliWealth treats it as context - not proof of intent or wrongdoing.
Source
Official filing ↗
Source: official House/Senate financial disclosure record · filing ID 20026063 · filed 2024-10-23 · disclosed 2d after transaction
Market context
Pfizer Inc.
Sector: Healthcare
Factual flags
- 5 nearby same-ticker disclosures in the surrounding 30-day window.
- Sits on committee with jurisdiction over pharma sector — traded PFE on 2024-10-21
Member trail
Laurel Lee
U.S. House · FL-15
House Committee on the JudiciaryHouse Committee on Energy and CommerceHouse Committee on House Administration
Ticker trail
$PFE
Pfizer Inc.
Follow this tickerAlert me when this ticker gets a new congressional receipt. This page reports public disclosures and factual context only. It does not determine intent, is not an accusation, and is not investment advice.